posted on 2020-10-26, 09:30authored byAntoni G Wrobel, Donald J Benton, Saira Hussain, Ruth Harvey, Stephen R Martin, Chloë Roustan, Peter B Rosenthal, John J Skehel, Steven J Gamblin
The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.
Funding
Crick (Grant ID: 10143, Grant title: Rosenthal FC001143)
Crick (Grant ID: 10078, Grant title: Gamblin FC001078)
Crick (Grant ID: 10030, Grant title: McCauley FC001030)